PTGX Jan 2025 30.000 call
| Previous Close | 7.60 |
| Open | N/A |
| Bid | 6.50 |
| Ask | 11.00 |
| Strike | 30.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 7.60 - 7.60 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
Investor's Business DailyProtagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
Protagonist Therapeutics is poised to join the S&P SmallCap 600 next Wednesday, replacing copper and aluminum wire manufacturer Encore Wire.
PR NewswireProtagonist Therapeutics Set to Join S&P SmallCap 600
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
Insider MonkeyIs Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Protagonist Therapeutics, Inc. (NASDAQ:PTGX) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
